The effect of dorzolamide on aqueous humor dynamics in normal human subjects during sleep

Ophthalmology

Volumn 105, Issue 8, 1998, Pages 1537-1540

  Vanlandingham, Benjamin D ^a   Maus, Todd L ^b   Brubaker, Richard F ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; PLACEBO;

ADULT; AQUEOUS HUMOR FLOW; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP; TOPICAL DRUG ADMINISTRATION; WAKEFULNESS;

EID: 0031793601     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(98)98043-5     Document Type: Article

References (22)

1. Becker B. Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, Diamox: a preliminary report. Am J Ophthalmol 1954;37:13-5.
2. Becker B. The effects of the carbonic anhydrase inhibitor, acetazolamide, on the composition of the aqueous humor. Am J Ophthalmol 1955;40 (Part II):129-36.
3. Wang R-F, Serle JB, Podos SM, Sugrue MF. MK-507 (L-671,152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys. Arch Ophthalmol 1991;109:1297-9.
4. Yamazaki Y, Miyamoto S, Sawa M. Effect of MK-507 on aqueous humor dynamics in normal human eyes. Jpn J Ophthalmol 1994;38:92-6.
5. Berson FG, Epstein DL. Separate and combined effects of timolol maleate and acetazolamide on open-angle glaucoma. Am J Ophthalmol 1981;92:788-91.
6. Epstein DL, Grant MW. Carbonic anhydrase inhibitor side effects: serum chemical analysis. Arch Ophthalmol 1977;95: 1378-82.
7. Strahlman E, Tipping R, Vogel R, the International Dorzolamide Study Group. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), Timolol and Betaxolol. Arch Ophthalmol 1995;113:1009-16.
8. Wilkerson M, Cyrlin M, Lippa EA, et al, the International Dorzolamide Study Group. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol 1993;111:1343-50.
9. Biollaz J, Munafo A, Buclin T, et al. Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide. Eur J Clin Pharmacol 1995;47: 453-60.
10. Maus TL, Larsson L-I, McLaren JW, Brubaker RF. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans. Arch Ophthalmol 1997;115: 45-59.
11. Ericson LA. Twenty-four hour variations in the inflow of the aqueous humor. Acta Ophthalmol (Copenh) 1958;36:381.
12. Reiss GR, Lee DA, Topper JE, Brubaker RF. Aqueous humor flow during sleep. Invest Ophthalmol Vis Sci 1984;25:776-8.
13. Topper JE, Brubaker RF. Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep. Invest Ophthalmol Vis Sci 1985;26:1315-9.
14. McCannel CA, Heinrich SR, Brubaker RF. Acetazolamide but not timolol lowers aqueous humor flow in sleeping humans. Graefes Arch Clin Exp Ophthalmol 1992;230:518-20.
15. Koskela T, Brubaker RF. Apraclonidine and timolol: combined effects in previously untreated normal subjects. Arch Ophthalmol 1991;109:804-6.
16. Johnson S, Coakes RL, Brubaker RF. A simple photogrammetric method of measuring anterior chamber volume. Am J Ophthalmol 1978;85:469-74.
17. Brubaker RF. Clinical evaluation of the circulation of aqueous humor. In: Tarman W, Jaeger EA, eds. Duane's Clinical Ophthalmology, revised ed. Philadelphia; JB Lippincott, 1994;3(ch 46):1-11.
18. Maren TH, Haywood JR, Chapman SK, Zimmerman TZ. The pharmacology of methazolamide in relation to the treatment of glaucoma. Invest Ophthalmol Vis Sci 1977;16:730-42.
19. Racz P, Ruzsonyi MR, Nagy ZT, et al. Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol. Arch Ophthalmol 1996;114:268-73.
20. Larsson L-I, Rettig ES, Brubaker RF. Aqueous flow in open-angle glaucoma. Arch Ophthalmol 1995;113:283-6.
21. Wilensky JT, Gieser DK, Dietsche ML, et al. Individual variability in the diurnal intraocular pressure curve. Ophthalmology 1993;100:940-4.
22. Frampton P, Da Rin D, Brown B. Diurnal variation of intraocular pressure and the overriding effects of sleep. American Journal of Optometry and Physiological Optics 1987;64:54-61.